Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine in Melancholic Bipolar II Depression
NCT02989727Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Nov 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lamotrigine in Bipolar II disorder (BP-II) (4 arms), sponsored by University of Saskatchewan. Primary endpoints: Montgomery-Asberg Depression Rating Scale Change Scores at 8 weeks, Hamilton Depression Rating Scale Change Scores at 8 weeks and 2 more. Started Nov 2003; status: completed.
02
Drugs
lamotrigine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT02989727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989727.